Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN7 | P35236 | 5/20 | 0.50 |
| ▸ | HMGCR | P04035 | 5/20 | 0.50 |
| ▸ | RECQL | P46063 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | SELP | P16109 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2122055 | 0.93 | HMGCR (0.44) | PTPN7HMGCRRECQLTDP1KDM4E | |
| SCHEMBL2123956 | 0.93 | PTPN7 (0.40) | PTPN7HMGCRRECQLTDP1KDM4E | |
| SCHEMBL15456677 | 0.84 | PTPN7 (0.59) | PTPN7HMGCRRECQLTDP1KDM4E | |
| SCHEMBL26187661 | 0.84 | PTPN7 (0.48) | PTPN7HMGCRRECQLTDP1KDM4E | |
| SCHEMBL16939030 | 0.83 | — | — | |
| SCHEMBL2121988 | 0.83 | PTPN7 (0.62) | PTPN7HMGCRRECQLTDP1KDM4E | |
| SCHEMBL30011879 | 0.83 | PTPN7 (0.62) | PTPN7HMGCRRECQLTDP1KDM4E | |
| SCHEMBL2124511 | 0.83 | PTPN7 (0.62) | PTPN7HMGCRRECQLTDP1KDM4E | |
| SCHEMBL2124505 | 0.83 | ALDH1A1 (0.44) | PTPN7HMGCRRECQLTDP1KDM4E | |
| SCHEMBL13144605 | 0.81 | HMGCR (0.50) | PTPN7HMGCRRECQLTDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2442783-B1 | NOVEL DEODORISING COMPOSITIONS AND DEODORISING PRODUCTS CONTAINING SAME | ROBERTET SA (FR) | 2017-08-09 | — | — | EP | claimed |
| US-9265852-B2 | Deordorising compositions and deodorising products containing same | ROBERTET S.A. (FR) | 2016-02-23 | — | — | US | claimed |
| US-20120201778-A1 | NOVEL DEORDORISING COMPOSITIONS AND DEODORISING PRODUCTS CONTAINING SAME | ROBERTET S.A. (FR) | 2012-08-09 | — | — | US | claimed |
| EP-2272491-A1 | New deodorising compositions and deodorant products containing them | Robertet S.A. (FR) | 2011-01-12 | — | — | EP | claimed |
| EP-2442783-B1 | NOVEL DEODORISING COMPOSITIONS AND DEODORISING PRODUCTS CONTAINING SAME | ROBERTET SA (FR) | 2017-08-09 | — | — | EP | disclosed |
| US-9265852-B2 | Deordorising compositions and deodorising products containing same | ROBERTET S.A. (FR) | 2016-02-23 | — | — | US | disclosed |
| US-20120201778-A1 | NOVEL DEORDORISING COMPOSITIONS AND DEODORISING PRODUCTS CONTAINING SAME | ROBERTET S.A. (FR) | 2012-08-09 | — | — | US | disclosed |
| EP-2442783-A2 | NOVEL DEODORISING COMPOSITIONS AND DEODORISING PRODUCTS CONTAINING SAME | Robertet S.A. (FR) | 2012-04-25 | — | — | EP | disclosed |
| US-8093427-B2 | Construction and screening of solution-phase derived library of fenbufen and ethacrynic acid | NATIONAL TSING HUA UNIVERSITY (TW) | 2012-01-10 | — | — | US | disclosed |
| US-20110306668-A1 | CONSTRUCTION AND SCREENING OF SOLUTION-PHASE DERIVED LIBRARY OF FENBUFEN AND ETHACRYNIC ACID | NATIONAL TSING HUA UNIVERSITY (TW) | 2011-12-15 | — | — | US | disclosed |
| EP-2272491-A1 | New deodorising compositions and deodorant products containing them | Robertet S.A. (FR) | 2011-01-12 | — | — | EP | disclosed |
| WO-2010146258-A2 | NOVEL DEODORISING COMPOSITIONS AND DEODORISING PRODUCTS CONTAINING SAME | ROBERTET S.A. (FR) | 2010-12-23 | — | — | WO | disclosed |
| US-6333441-B1 | FORMING MIXTURE COMPRISING FORMIC ACID, TRIETHYLAMINE, TRIBUTYLPHOSPHINE, AND TRIS(DIBENZYLIDENEACETONE) DIPALLADIUM (0)-CHLOROFORM ADDUCT IN SOLVENT, ADDING THERETO ALKYNE UNDER EFFECTIVE REDUCTION CONDITIONS | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2001-12-25 | — | — | US | disclosed |
| EP-0560532-B1 | Preparation of cis-olefins | NISSAN CHEMICAL IND LTD (JP) | 1999-08-04 | — | — | EP | disclosed |
| EP-0560532-A1 | Preparation of cis-olefins | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1993-09-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110306668-A1 | CONSTRUCTION AND SCREENING OF SOLUTION-PHASE DERIVED LIBRARY OF FENBUFEN AND ETHACRYNIC ACID | CYP4F2, ACR, CYP4F3 | PTPN7 2674/4885HMGCR 103/4885RECQL 1351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.